video thumbnail

Cholecystitis and Cholelithiasis - Pathophysiology and Clinical Features

Duration: 11:42

Write A New Comment




Oct 16 2020, 6:59 pm

Hello sir i m here for diagrammatic representation and more dynamic understanding of this disease but here i am getting podcast of this disease...... is this correct way for study???

Also sir i am disappointed by acute abdomen series the tutor in volume 1 only explaimed 1 sign and then tutor in volume 2 in acute appendicitis told that we have already discussed all the signs in vol.1 

Now sir u tell me whom to beileve coz signs arent discussed in any lecture 

Also sir i m quite disappointed with dr been subrcription i thought it would be more diagrammatic and clinical feature but i was wrong 

But i also appreciate all your efforts in ecg series i have watched it thoroughly and i am quite satisfied by that series

I hope you will improve some of the content



Aug 14 2019, 5:22 am

I find it interesting the issues that people have post choleycystectomy. It seems as though it brings on a new series of chronic issues. For example, increasing serum bile acid levels, the changes in pH in the intestines, the different composition of bile that freely flows into the intestines vs the composition of gallbladder bile that is concentrated. The changes in the signalling system with the FGF-19. The increased risk for colon cancer. Thanks for the lecture Dr. Mobeen. It's a pleasure.



Aug 13 2019, 9:46 pm

It is correct that certain normal functions get disrupted, and most importantly the possibility of carcinomas in certain cases increase.


95% of the gallbladder diseases are cholelithiasis (gallstones.)

About 2% of the US health budget goes towards the management of cholelithiasis and its complications.

10%-20% of the population in the western hemisphere has gallstones.
25-50 tons of the gallstones are carried by more than 20 million Americans.

In the US about 1 million new cases are diagnosed annually, out of these, 2/3 will undergo surgery for the gallstones.

Gallstones are of two main types. 80% are cholesterol stones. Consisting of crystalline cholesterol monohydrate. The remainder are mainly bilirubin calcium salts and are called pigment stones.


High-Level Pathophysiology

The basic reason for the formation of the cholesterol stones is the following:
They only path for the cholesterol removal from the body is via the bile system. Cholesterol is not water soluble. We need to make it water soluble to traverse this path. To solve this, our body forms bile salts and lecithins. These bind with cholesterol and allow the passage through the bile system. These salts and lecithins are like boats on the water to which cholesterol is bound. If the quantity of the cholesterol is more than the binding capacity of these salts, then the unbound cholesterol forms cholesterol monohydrate crystals. These crystals precipitate in solid form. These precipitations irritate the gallbladder layers that in turn release mucus which traps these solid structures in the gallbladder resulting in the stone formation.
In summary, the following four events occur simultaneously for the formation of a gallstone:
1. Amount of cholesterol more than the binding capacity of the bile salts (supersaturation.)
2. Formation of the cholesterol monohydrate crystals.
3. Precipitation and aggregation of these crystals forming solid stone particles.
4. Mucus secretion by the gallbladder's inner surface resulting in the entrapment of these solid particles in the gallbladder.


Pigment Stones 

These stones are predominantly composed of bilirubin calcium salts. Their formation is a complex phenomenon. However, it is clear that the presence of unconjugated bilirubin in the bile tree predisposes to the formation of the pigment stones. An example is hemolytic anemia, where the premature RBC breakdown overwhelms the hepatocyte's bilirubin conjugation capacity and the unconjugated bilirubin appears in blood plasma and bile. Infections of the biliary tree can also result in unconjugated bilirubin in the bile.

Also, note that the prevalence of the gallstones is age and gender-related.
Population < 40 has 5% to 6% prevalence of the gallstones.
Population > 80 y has 25% to 30% prevalence of the gallstones.

Prevalence in white women is twice as high as in men.

Ethnic and geographic
The native American population has a 75% prevalence of cholesterol gallstones. Pigment stones are rare in this group.
Gallstones are more prevalent in western industrialized societies compared to the developing countries.

Robins 8th Edition Page 667


Cholelithiasis (Gallstones). Clinical Features.

Frequently cholelithiasis is asymptomatic. It is usually discovered during a  radiographic study or during a surgery, or an autopsy.

Clinical features of gallstones occur due to the obstruction and inflammation of the gallbladder by a large stone, or the small stones that move down in the biliary tree and get stuck in it, or due to the irritation and inflammation of the biliary tree.

Pain is usually excruciating (severe). It may be constant or colicky. The pain of acute cholecystitis is in the upper right quadrant can be associated with fever, nausea, and a positive Murphy's sign.  Biliary or episodic gallbladder pain occurs in 10-25% of the patients. Acute cholecystitis occurs in 20% of these symptomatic patients.

Occasionally gallstone ileus or Bouveret or Mirizzi syndrome occurs as a clinical complication of a gallstone. Bouveret syndrome occurs when the stone obstructs pylorus or duodenum.

Murphy's sign is positive when you palpate the upper right quadrant during inspiration, and the patient's breathing is interrupted or stopped due to the pain.

You can also perform an indirect fist percussion to compare any difference in pain in the right upper quadrant and the left upper quadrant.

Robbins 8th Edition: Page 668
Current Medical Diagnosis and Treatment 2016 - Cholelithiasis chapter.

In this video we will learn about:

1. Epidemiology of gallbladder pathologies.

2. Cholesterol stones vs. pigment stones

3. Pathophysiology of cholelithiasis.

4. Prevalence.

5. Clinical presentation and examination findings of acute cholecystitis.

6. Risk factors for acute attacks.

Presented by Dr. Mobeen Syed

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.


In addition to the presenter, following authors may have helped with the content writing, review, or approval:

  • Dr. Mobeen Syed

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty Disclosures
Dr. Mobeen Syed Author declares no conflict of interest.


Dr. Mobeen Syed

Dr. Mobeen Syed

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

Dr. Pei's Family Practice Syllabus

Related Videos